Common-Size Balance Sheet: Assets
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
The asset composition of the entity shows a consistent distribution between current and long-term assets over the five-year period from 2017 to 2021. Current assets generally represent approximately 30% of the total asset base, while long-term assets account for the remaining 70%, indicating a capital-intensive structure typical of the biotechnology sector.
- Liquidity and Current Asset Management
- Cash and cash equivalents exhibit significant volatility, fluctuating from a low of 4.84% in 2018 to a peak of 10.70% in 2019, ending at 9.47% in 2021. Short-term marketable securities have experienced a gradual decline from 8.94% to 6.45% over the period. Accounts receivable have remained relatively stable, oscillating between 6.49% and 7.77%. A modest upward trend is observed in inventory, which increased from 3.82% in 2017 to 5.66% in 2021, suggesting a potential increase in product stockpiling or a change in supply chain requirements.
- Intangible Assets and Goodwill
- There is a notable divergence between goodwill and other intangible assets. Goodwill has steadily increased as a percentage of total assets, rising from 19.59% in 2017 to 24.13% in 2021, which typically indicates growth through acquisitions. Conversely, net intangible assets have seen a marked decline, dropping from 16.40% in 2017 to 9.30% in 2021, likely reflecting the systematic amortization of acquired intellectual property.
- Long-term Investment and Fixed Assets
- Long-term marketable securities have decreased substantially, falling from 12.93% in 2017 to 3.74% in 2021, indicating a reallocation of capital away from long-term financial instruments. Property, plant, and equipment have remained consistent, averaging around 13-14% of total assets. Investments and other assets showed a significant increase from 1.82% in 2017 to a peak of 11.78% in 2020, before settling at 8.12% in 2021.
- Tax and Lease Assets
- Deferred tax assets experienced a period of growth, peaking at 11.87% in 2019 before returning to a range of 5.56% to 5.93% by 2021. Operating lease assets appeared in 2019 following accounting standard changes, maintaining a stable presence of approximately 1.57% of total assets through 2021.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?